Quotientbd blood bank transfusion reagents
Ended Awarded Last action
- Contract number
- 36C25924N0257
- Awardee
-
Alba Bioscience, Inc. UEI V6KNKL6BDHL7
- Awarding agency
-
Veterans Integrated Service Network 19
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $20,527
Award facts
- Contract value 100% obligated
- $20,527.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Chicago, IL 60607, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$26,744 | |
| Funding Only Action | -$7,655 | |
| Original award | $54,925 |
About this award
Alba Bioscience, Inc. was awarded a $20,527.19 firm fixed-price Blanket Purchase Agreement (BPA) call for Quotient blood bank transfusion reagents by Veterans Integrated Service Network 19 on June 1, 2024, with completion targeted for May 31, 2025. The contract, which utilizes no set-aside designation, is established under the GSA Schedule 65-VII for in vitro diagnostics, reagents, and tests. Alba Bioscience, a Chicago-based subsidiary of Quotient Biodiagnostics specializing in blood banking supplies and diagnostic testing materials, will perform the work at its Chicago location. The award represents a call order against an existing BPA vehicle, enabling the VA medical facility to procure specialized blood bank reagents essential for immunohematology testing and blood typing operations.
This contract supports the Veterans Health Administration's mission to provide comprehensive healthcare services to veterans across the VA's integrated service network system. Alba Bioscience has established itself as a critical supplier of blood banking diagnostics to federal healthcare agencies, with a portfolio that includes antibody screening cells, antibody identification panels, red blood cell reagents, and quality control materials. The firm fixed-price structure ensures cost predictability for the government while Alba Bioscience leverages its expertise in producing highly specialized medical products required for blood transfusion services and diagnostic laboratory operations within the VA healthcare system.
Quick answers
Who was awarded contract 36C25924N0257?
36C25924N0257 was awarded to Alba Bioscience, Inc. by Veterans Integrated Service Network 19 (Veterans Health Administration) on June 1, 2024.
How much is contract 36C25924N0257 worth?
The government has obligated $20,527 on 36C25924N0257.
Is contract 36C25924N0257 an order under another contract?
Yes. 36C25924N0257 is a BPA call under 36F79721D0259-36C25923A0014, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25924N0257 competed?
The extent of competition for 36C25924N0257 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award